The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lessons from the 1970s

Thu, 09th Feb 2023 11:20

STOXX 600 up 1.1%

*

German inflation dips

*

Takeover talk boosts StanChart

*

U.S. stock futures rise

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

LESSONS FROM THE 1970S (1102 GMT)

Inflation finally appears to be cooling off. Data released from Germany on Thursday showed EU-harmonised consumer prices rose by 9.2% in January, down from 9.6% in December and below expectations of 10%.

In the U.S., headline CPI has fallen from a peak of 9.1% in June last year to 6.5% in December. January data, released next week, could well show annual inflation slowed further last month.

"Our models suggest it will continue downward. Fast," says Henry Neville, portfolio manager at Man Solutions, who expects headline CPI to reach 2% this year.

However, as Neville points out, if inflation is not under control, then there's always a possibility it'll rear its head once again and inflationary waves similar to the 1970s could become more commonplace.

"Inflation is like the Terminator chasing Sarah Connor," he says. "Until it's completely destroyed ... it will keep coming back."

Neville says to really end inflationary waves similar to those observed in the 1970s, then U.S. interest rates would need to peak closer to 9% as is today implied by the Taylor Rule. This is well above market pricing for peak rates of around 5%.

One of the lessons from the 1970s, according to Neville, is that even though high inflation decades are, overall, not good times to hold equity risk, the periods in between the waves can deliver very strong returns.

"A period of disinflation is generally a time when the market rallies," Neville says.

"We continue to see the next couple of quarters as being risk-positive, and expect stocks to continue to climb the wall of worry."

THE GERMAN INFLATION BRAIN TEASER (1051 GMT)

Germany's lower-than-expected headline inflation offers some relief to the fixed-income market, but analysts are having trouble assessing the outlook.

"The methodological uncertainty around the inflation figures for December 2022 and January and February 2023 is much higher than usual," says Salomon Fiedler, an economist at Berenberg.

"The government is intervening heavily in household energy markets, but it is, a priori, unclear to which extent this will show up in the data collected by the statisticians," he adds.

German consumer prices rose by 9.2% in January.

"The energy price cap will come into effect as of 1 March but will be paid retroactively," ING analysts note.

"According to Bundesbank estimates, energy price caps and cheap public transportation tickets will lower average German inflation by 1.5 percentage points this year," they say.

And there is more. "Negative base effects from last year's energy relief package for the summer months should automatically push up headline inflation between June and August," they add.

Bottom line, according to Citi analysts, "today's data does not yet necessarily imply that core or underlying inflation is on a lower path, nor that the surprise is persistent."

STOXX: ACTION-PACKED START (0936 GMT)

There was no lack of action at the open today in Europe with corporate dealmaking, earnings reports and a softer-than-expected inflation print in Germany sparking broad-based gains and pushing indices to fresh highs.

Well-received numbers from drugmaker AstraZeneca drove the FTSE 100 to a new lifetime peak, up 1.1%.

Also helping was a spike of over 10% in StanChart after a Bloomberg reported that First Abu Dhabi Bank is still considering a potential offer for the UK bank. On the downside, Entain slumped 10% after U.S-based MGM Resorts said it was no longer from pursuing an offer for the gambling firm.

The STOXX 600 meanwhile rose 0.8% to a fresh 10-month high, although gains were capped by some disappointing updates from Delivery Hero and GN Store Nord.

In banks, Credit Suisse saw its worst annual loss since 2008, sending its shares down 6%. Credit Agricole posted strong numbers, pushing its shares higher.

EUROPEAN SHARES SET FOR POSITIVE START (0737 GMT)

Shares in Europe are expected to rise this morning, tracking a bounce in U.S. futures and following data showing German inflation rose by a less than anticipated 9.2% in January, which could ease pressure on the ECB to keep raising rates.

EuroSTOXX 50 and FTSE futures are up 0.6% and 0.3%, respectively, and S&P 500 contracts added 0.4%.

On another heavy day in Europe's earnings season, eyes are on Credit Suisse. The Swiss bank posted its worst annual loss since 2008 and warned that a further "substantial" loss would come this year. Its shares were down 4.7% in the premarket.

On a more upbeat note, Credit Agricole posted a higher-than-expected profit, driven by lower loan provisions and a strong performance at its investment banking division.

In the UK, Unilever reported quarterly underlying sales growth above expectations and AstraZeneca posted fourth-quarter revenue just shy of analyst estimates.

BAR-DUH (0656 GMT)

Surely the most fun story today, unless you are an Alphabet shareholder, is Google's new Bard AI flunking a question on the James Webb telescope. And it was an own goal given the error was in a Twitter video put out by Google itself, ouch.

Alphabet's shares sank almost 8%, wiping a cool $100 billion off its market cap, and dragging all of Wall Street down. But it did produce one of our best headlines of the session: "Alphabet's Bard apparently no Shakespeare." Eat your heart out AI.

There's been scant fun in Asian markets with everyone already stressing about next week's U.S. CPI report and what that will mean for the likely peak of Fed rates.

In Europe, the Riksbank meeting will be interesting if only because both the governor and deputy are new to the roles, so there's no knowing if the central bank's reaction function has changed.

Markets are priced for a half-point hike to 3.0%, in part to match the ECB and stop the SEK from weakening yet further. It's been falling steadily on the euro since late 2021, making it all the harder to fight inflation.

Assuming it goes 50 bps, and not 75 bps, the focus will be on the outlook for further tightening. Markets are fully priced for a move to 3.25%, with 3.5% an even bet.

If this week's hikes by central banks in India and Australia are anything to go by, the risk is for a hawkish outcome in Sweden.

Further out, JPMorgan analysts note household debt in Sweden is twice the EU average making it tough for the Riksbank to keep a half-point spread over ECB rates.

"Monetary policy in Sweden is clearly more restrictive than in the Euro-area," they say. "If the ECB therefore ends up with a 3.25% terminal rate (our forecast), we think the Riksbank will not be able to follow suit and take the policy rate to 3.75%."

There are blessedly no Fed speakers today, but Bank of England Governor Andrew Bailey will be grilled by lawmakers - among the few people in the country not on strike - about its recent rate rise and the ever-growing risk of recession.

The BoE line has been they may have done enough, but are not sure and are ready to do more if needed.

Key developments that could influence markets on Thursday:

- Riksbank rate decision and Feb monetary policy report due at 0830 GMT. Governor Erik Thedéen and Jesper Hansson, head of the Monetary Policy Department hold presser at 1000 GMT

- BoE Governor Bailey speaks to lawmakers at 0945 GMT

- The delayed German Jan CPI is due at 0700 GMT and could cause fireworks if stronger than the forecast 8.9% y/y

More News
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.